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Abstract
Hepatitis B core antigen (HBc Ag) and hepatitis B surface antigen (HBs Ag) were detected
in the liver tissue of a patient with chronic aggressive hepatitis by the immunofluorescent com-
plement technique. The presence of anti-HBc was examined by the same method in 67 human
sera previously tested for HBs Ag, anti-HBs and s-GPT levels. HBc Ag was localized mainly in
the nucleus and sometimes in the cytoplasm of the hepatic cells. HBs Ag was found only in the
cytoplasm. The focal area of HBc Ag positive hepatic cells seemed to correspond to the HBs Ag
positive cells. Double staining demonstrated the simultaneous presence of HBs Ag and HBc Ag
in individual cells. Anti-HBc positive serum was found in 46 (68.7%) cases. Forty-eight (71.6%)
indicated a combination of HBs Ag and anti-HBc.
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Abstract: Hepatitis B core antigen (HBc Ag) and hepatitis B sur-
face antigen (HBs Ag) were detected in the liver tissue of a patient
with chronic aggressive hepatitis by the immunofluorescent comple-
ment technique. The presence of anti-HBc was examined by the
same method in 67 human sera previously tested for HBs Ag, anti-
HBs and s-GPT levels. HBc Ag was localized mainly in the nucleus
and sometimes in the cytoplasm of the hepatic cells. HBs Ag was
found only in the cytoplasm. The focal area of HBc Ag positive
hepatic cells seemed to correspond to the HBs Ag positive cells.
Double staining demonstrated the simultaneous presence of HBs Ag
and HBc Ag in individual cells. Anti-HBc positive serum was found
in 46 (68.7%) cases. Forty-eight cases (71.6%) indicated a combination
of HBs Ag and anti-HBc.
It is not clear at present whether hepatitis B antigen (HB Ag) is local-
ized in the nucleus or cytoplasm of the hepatic cell. HB Ag is separated into
HBs Ag found on the surface of the Dane particle (1) and HBc Ag found in
the core of the particle. The former has been found to be localized in the
cytoplasm and the latter in the nucleus (2). The antibody to serum HBc Ag
(anti-HBc) of patients with hepatitis B virus (HBV) infection has been investi-
gated by the complement fixation (CF) reaction (3). The CF reaction re-
quires a large amounts of purified HBc Ag. In practice, however, the yield
from the serum of an asymptomatic carrier is quite low as the amount of
Dane particles in the HB Ag particles is small (4). The present study uses
the complement method of fluorescent antibody technique (5) to demonstrate.




Tsuji et al.: Detection of liver HBc antigen and its antibody in sera from
Produced by The Berkeley Electronic Press, 1976
62 T. TSUJI et al.
MATERIALS AND METHODS
Liver tissue positive for BBs Ag from one patient with chronic aggressive
hepatitis (7) was frozen and sliced to 4 J1 thickness using a cryostat. The sec-
tions were fixed for 3 min in cold acetone and used as antigen. Acetone-fixed
sections were covered by one drop of a mixture of specific anti-BBc prepared
from immunized guinea pigs and complement or inactivated human serum and
complement. The human serum was obtained from liver disease patients and
from normal controls from the following three group: 26 cases with BBs Ag
p::>sitive serum, 15 cases with anti BBs positive serum and 26 cases with BBs Ag
negative and anti-BBs negative serum. The serum was diluted to I : 5. As
complement, a drop of mixture containing the same volume of diluted serum
solution at I : 2 obtained from guinea pigs (Kyokuto Co.) was used. The slides
were incubated at 37°C for one hour. After washing with phosphate buffer
saline (PBS), one drop of fluorescein isothiocyanate (FITC)-labelled anti-guinea
pig ( globulin solution was added. The antibody titer was 64 or higher in 125 ftg
of antigen protein by the micro-Ouchterlony method using immunized rabbits
from our colony, and the ratio of FITC to protein was 1.5. The slides were
incubated at 37°C for 40 min. After washing with PBS, the slides were covered
and observed by fluorescent microscopy.
For comparative purposes, the following method were used for detection of
BBs Ag and HBc Ag: (a) double staining (8) with FITC-labelled anti-HBs and
tetramethyl rhodamine (TMR)-labelled anti-complement solution; (b) another
complement method; (c) the direct and indirect fluorescent staining methods;
and (d) the indirect fluorescent staining method. The other complement method
used staining of fresh human serum complement and FITC-Iabelled anti-human
Clq, C4 or C3 solutions (Meloy Lab.). The indirect method (6) used anti-HBc
and FITC-Iabelled human IgG solution (Behringwerke Institute).
Serum glutamic pyruvic transaminase (s-GPT) activity was measured ac-
cording to Reitman and Frankel (9). Tests for HBs Ag were performed by two
methods: the immunoelectrophoretic (IEP) method described by Bussard and
Huet (10) and the more sensitive immune adherence hemagglutination (IAHA)
method described by Mayumi, Okochi and Nishioka (11). The anti-HBs tests
were performed by IEP (10) and the passive hemagglutination (PHA) method
according to the description of Vyas and Shulman (12). Purified HBs Ag and
HBc Ag were prepared with the modified method of sucrose instead of cecium-
chloride (13).
RESULTS
HBs Ag was detected in the cytoplasm of hepatic cells by the comple-
ment method and by both the indirect and direct methods (Fig. 1). HBc Ag
stained by the complement method was granular all around the cytoplasm,
near the membrane and in the nucleus of the hepatic cells (Figs. 2, 3). On
staining with human complement method, HBc Ag was stained more clearly
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Fig. 1. Localization of HBs Ag in liver section from a case with chronic aggressive
hepatitis by direct method. HBs Ag is localized only in the cytoplasm of hepatic cells and
demonstrates the focal nature of the specifically stained cells. This corresponds to the
characteristic focal spotty necrosis seen in viral hepatitis. X 400.
Fig. 2. The localization of HBc Ag in liver tissue from the same case using the guinea
pig complement method. HBc Ag is localized mainly in the nucleus and sometimes in the
cytoplasm of the hepatic cells. The focal nature of cells stained specifically corresponds
to the localization of HBs Ag. >: 400.
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Fig. 3. This figure also demonstrates the localization of HBc Ag in another section.
Hepatic cells with specifically stained nucleus are localized side by side from the peripheral
to the central portions. Hepatic cells with stained nucleus are localized in the periphery,
and the hepatic cells with stained nucleus and cytoplasm are in the center. x400.
Fig. 4. HBc Ag and HBs Ag by the double staining method. The black arrows indicate
reddish-brown fluorescence (HBc Agl; and the open arrows indicate yellow-green fluore-
scence (HBs Ag). x 400.
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in the nucleus with FITC-Iabelled anti-C3 solution than with FITC-Iabelled
anti-Clq or FITC-Iabelled anti-C4 solutions. The HBc Ag areas of the hepatic
sections corresponded to those of HBs Ag positive regions. Double staining
demonstrated HBs Ag and HBc Ag in the same hepatic cells (Fig. 4).
Anti-HBc positive serum cases with both 'HBs Ag positive· and HBs Ag
negative sera constituted a total of 46 (68.70/0) of 67 cases (Table 1). Among
TABLE 1. HBs AG AND ANTI-HBs RELATIONSHIP TO ANTI-HBc BY THE
IMMUNOFLUORESCENT COMPLEMENT METHOD
HBs Anti- Cases Cases with s-GPT normal/abnormalAg HBs anti-HBc ('Yo) (No. of anti-HBcl
.--- -.. - ---- --_.__ .._-~._---------------_._._-
+ 26 26 (100.0) 20 (20) / 6 ( 6)
+ 15 13 ( 86.7) 12 (12) / 3 ( Ii
26 7 ( 26.9) II ( 3) /15 ( 4)
Total 67 46 ( 68.7) 43 (35) /24 (11)
-~----_. -----.
HBs Ag (+): IEP and IAHA, positive; anti-HBs (+): PHA, positive
15 cases with negative HBs Ag, negative anti-HBs and abnormal s-GPT
levels, four cases (26.7%) were positive for anti-HBc.
Positive complement tests were found for anti-HBc in a HBs Ag blood
donor with PBS dilution titers of 2,4,5, 10 and 20 (-ttt), 40 and 80 (-t+) and
160 and 320 (+). The indirect method on this serum with FITC-labelled
anti-human IgG yielded weak fluorescence at dilution titers of 2, 4 and 5 (+)
and unclear fluorescence at dilution liters of 10 or greater (Table 2). This
comparative study showed that the complement method was 100 times more
sensitive than the indirect method.
TABLE 2. COMPARISON OF THE GUINEA PIG COMPLEMENT METHOD AND THE INDIRECT
METHOD USING ANTI-HBc FROM SERUM OFA BLOOD DONOR WITH
HBs AG AND NORMAL s-GPT LEVEL
2 4 10
Oil ution by PBS
20 40 80 160 320 640 l,280
++-r++++i-jComplementmethod
Indirect +
method ._.__+__ .._. ~_.__±__....__.__
Htt, very strong fluorescence; +t, strong fluores.::ence; +, weak fluorescence; ±" unclear
fluorescence; -, negative fluorescence.
DISCUSSION
We first reported in Japan that HB Ag was localized mainly in the
nucleus and slightly in the cytoplasm of hepatic cells using the di.rect method
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with human anti-HB (14). It was difficult, however, to conduct experimental
studies with antibody in animals. In the present follow-up study, human and
guinea pig antibodies to HBc Ag were successfully demonstrated as having
strong complement fixation to anti-HBc. The procedure used here is notable
because it determines anti-HBc in serum rather simply.
Hoofnagle, Gerety and Barker (3) pointed out on anti-HBc with the CF
reaction that cases with positive anti-HBc often had positive HBs Ag or anti-
HBs. Our present findings on serum correspond closely with the results of
the investigators.
However, among cases with positive anti-HBc without HBs Ag and anti-
HBs, especially with abnormal s-GPT levels or so-called non-B hepatitis,
4 of 15 cases (26.7%) were found to be positive for anti-HBc. Forty-eight
cases (71.6%) showed positive HBs Ag and positive anti-HBe, and all these
cases probably had HBV.
On the other hand, our findings by double staining technique indicated
that HBV proliferates in infected hepatic cells. The sequence of the Ag pro-
duction may proceed as follows: (a) the hepatic cells are affected by HBV,
(b) HBc Ag is produced in the nucleus of the hepatic cell; (c) HBs Ag
is produced in the cytoplasm, and (d) HBs Ag or HBc Ag coated with HBs
Ag appears in serum.
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